{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:21:38Z","timestamp":1771917698203,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.soc.2022.10.003","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T19:26:24Z","timestamp":1678821984000},"page":"251-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Nomogram for Relapse\/Death and Contemplating Adjuvant Therapy for Parathyroid Carcinoma"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-7072","authenticated-orcid":false,"given":"Angelica M.","family":"Silva-Figueroa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.soc.2022.10.003_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib2","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.surg.2014.08.069","article-title":"Parathyroid carcinoma in more than 1,000 patients: A population-level analysis","volume":"156","author":"Sadler","year":"2014","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.soc.2022.10.003_bib3","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1007\/s00432-021-03576-9","article-title":"Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort","volume":"147","author":"Kong","year":"2021","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"9","key":"10.1016\/j.soc.2022.10.003_bib4","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1245\/s10434-018-6559-6","article-title":"Tumor size and presence of metastatic disease at diagnosis are associated with disease-specific survival in parathyroid carcinoma","volume":"25","author":"Lo","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soc.2022.10.003_bib5","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Of Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2022.10.003_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Third International Workshop on the Management of Asymptomatic Primary H. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J\u00a0Of Clin Endocrinol And Metab"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2022.10.003_bib7","first-page":"80","article-title":"Parathyroid Carcinoma: Diagnosis and Clinical Implications","volume":"31","author":"Duan","year":"2015","journal-title":"Turk Patoloji Derg"},{"issue":"11","key":"10.1016\/j.soc.2022.10.003_bib8","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1245\/s10434-019-07451-3","article-title":"Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center","volume":"26","author":"Asare","year":"2019","journal-title":"Ann Of Surg Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib9","article-title":"Contemporary Evaluation and Management of Parathyroid Carcinoma","author":"Fingeret","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.soc.2022.10.003_bib10","series-title":"Endocrine surgery comprehensive board exam guide","first-page":"379","article-title":"Diagnosis and Surgical Management of Parathyroid Carcinoma","author":"Silva-Figueroa","year":"2021"},{"issue":"1","key":"10.1016\/j.soc.2022.10.003_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO Classification of Parathyroid Tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.beem.2018.11.002","article-title":"Parathyroid carcinoma","volume":"32","author":"Salcuni","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.soc.2022.10.003_bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF02067369","article-title":"Prognostic factors in parathyroid cancer: a review of 95 cases","volume":"16","author":"Sandelin","year":"1992","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.soc.2022.10.003_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Clinical review 122: Parathyroid carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J\u00a0Of Clin Endocrinol And Metab"},{"issue":"7","key":"10.1016\/j.soc.2022.10.003_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/014556130408300718","article-title":"Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes","volume":"83","author":"Wiseman","year":"2004","journal-title":"Ear Nose Throat J"},{"issue":"8","key":"10.1016\/j.soc.2022.10.003_bib16","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1245\/s10434-010-1003-6","article-title":"Clinical presentation, staging and long-term evolution of parathyroid cancer","volume":"17","author":"Talat","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soc.2022.10.003_bib17","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J\u00a0Of Clin Endocrinol And Metab"},{"issue":"2","key":"10.1016\/j.soc.2022.10.003_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.suronc.2014.03.005","article-title":"Parathyroid carcinoma","volume":"23","author":"Al-Kurd","year":"2014","journal-title":"Surg Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jso.24407","article-title":"Oncologic progress for the treatment of parathyroid carcinoma is needed","author":"Christakis","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2022.10.003_bib20","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.soc.2022.10.003_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<378::AID-CNCR3>3.0.CO;2-F","article-title":"Parathyroid carcinoma: a diagnostic and therapeutic challenge","volume":"86","author":"Shaha","year":"1999","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.soc.2022.10.003_bib22","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1245\/s10434-012-2306-6","article-title":"Classification of parathyroid cancer","volume":"19","author":"Schulte","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib23","doi-asserted-by":"crossref","DOI":"10.2217\/ije-2017-0011","article-title":"Current and future treatments for parathyroid carcinoma","author":"Long","year":"2018","journal-title":"Int J Endocr Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib24","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"issue":"4","key":"10.1016\/j.soc.2022.10.003_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cen.14161","article-title":"Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data","volume":"92","author":"Zhu","year":"2020","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.soc.2022.10.003_bib26","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.ejso.2021.06.026","article-title":"Local resection versus radical surgery for parathyroid carcinoma: a national cancer database analysis","volume":"47","author":"Leonard-Murali","year":"2021","journal-title":"Eur J Of Surg Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib27","doi-asserted-by":"crossref","first-page":"784599","DOI":"10.3389\/fnins.2022.784599","article-title":"Prognostic Analysis for Patients With Parathyroid Carcinoma: A Population-Based Study","volume":"16","author":"Qian","year":"2022","journal-title":"Front Neurosci"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061426","article-title":"Parathyroid carcinoma: incidence, survival analysis, and management: a study from the seer database and insights into future therapeutic perspectives","volume":"14","author":"Ullah","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.soc.2022.10.003_bib29","doi-asserted-by":"crossref","first-page":"850457","DOI":"10.3389\/fendo.2022.850457","article-title":"A\u00a0Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study","volume":"13","author":"Tao","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.soc.2022.10.003_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3332\/ecancer.2020.1105","article-title":"Definition and assessment of frailty in older patients: the surgical, anaesthesiological and oncological perspective","volume":"14","author":"Dottorini","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"7","key":"10.1016\/j.soc.2022.10.003_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4158\/EP-2018-0538","article-title":"The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma: 20-year experience from a single institute","volume":"25","author":"Hu","year":"2019","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib32","first-page":"7276","article-title":"Clinical characteristics and treatment outcomes of parathyroid carcinoma: A retrospective review of 234 cases","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib33","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.surg.2014.08.005","article-title":"Is central lymph node dissection necessary for parathyroid carcinoma?","volume":"156","author":"Hsu","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2022.10.003_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2017.01.060","article-title":"Prognostic scoring system to risk stratify parathyroid carcinoma","author":"Silva-Figueroa","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.soc.2022.10.003_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13055","article-title":"Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients","author":"Xue","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.soc.2022.10.003_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0043-109562","article-title":"Parathyroid hormone levels predict long-term outcome after operative management of parathyroid cancer","volume":"49","author":"Machens","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.soc.2022.10.003_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-022-07403-w","article-title":"Tumor size rather than the thyroid invasion affects the prognosis of parathyroid carcinoma without lymph node or distant metastasis","author":"Sun","year":"2022","journal-title":"Eur Arch oto-rhino-laryngology"},{"issue":"2","key":"10.1016\/j.soc.2022.10.003_bib38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1245\/s10434-021-10962-7","article-title":"Extended En bloc reoperation for recurrent or persistent parathyroid carcinoma: analysis of 31 cases in a single institute experience","volume":"29","author":"Wei","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib39","series-title":"In WHO classification of tumors of endocrine organs","first-page":"145","article-title":"Tumors of the parathyroid glands","author":"DeLellis","year":"2017"},{"issue":"5","key":"10.1016\/j.soc.2022.10.003_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.surg.2014.05.014","article-title":"Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study","volume":"156","author":"Villar-del-Moral","year":"2014","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.soc.2022.10.003_bib41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","article-title":"Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"86","author":"Hundahl","year":"1999","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.soc.2022.10.003_bib42","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s00268-010-0722-y","article-title":"Lymph node involvement and surgical approach in parathyroid cancer","volume":"34","author":"Schulte","year":"2010","journal-title":"World J Surg"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2022.10.003_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12902-019-0368-1","article-title":"Current concepts in parathyroid carcinoma: a single Centre experience","volume":"19","author":"Ferraro","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"10.1016\/j.soc.2022.10.003_bib44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","article-title":"Clinical Course of Metastatic Parathyroid Cancer","volume":"18","author":"Sandelin","year":"1994","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.soc.2022.10.003_bib45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00774-021-01305-3","article-title":"Mortality factors in recurrent parathyroid cancer: a pooled analysis","volume":"40","author":"Tsai","year":"2022","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.soc.2022.10.003_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","article-title":"Understanding the genetic basis of parathyroid carcinoma","volume":"25","author":"Gill","year":"2014","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.soc.2022.10.003_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ando.2015.03.003","article-title":"Parathyroid carcinoma: Challenges in diagnosis and treatment","volume":"76","author":"Betea","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"10.1016\/j.soc.2022.10.003_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"issue":"7","key":"10.1016\/j.soc.2022.10.003_bib49","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A\u00a0nationwide study on parathyroid carcinoma","volume":"56","author":"Ryhanen","year":"2017","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"10.1016\/j.soc.2022.10.003_bib51","doi-asserted-by":"crossref","first-page":"e45567","DOI":"10.1371\/journal.pone.0045567","article-title":"Novel HRPT2\/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas","volume":"7","author":"Wang","year":"2012","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.soc.2022.10.003_bib52","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","article-title":"Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma","volume":"24","author":"Witteveen","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.soc.2022.10.003_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-020-01224-6","article-title":"Immunocyte density in parathyroid carcinoma is correlated with disease relapse","author":"Hu","year":"2020","journal-title":"J\u00a0endocrinological Invest"},{"key":"10.1016\/j.soc.2022.10.003_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid Carcinoma","volume":"51","author":"Cetani","year":"2019","journal-title":"Front Horm Res"},{"issue":"8","key":"10.1016\/j.soc.2022.10.003_bib55","doi-asserted-by":"crossref","first-page":"T53","DOI":"10.1530\/ERC-20-0018","article-title":"Hereditary endocrine tumours: current state-of-the-art and research opportunities: new and future perspectives for parathyroid carcinoma","volume":"27","author":"Perrier","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.soc.2022.10.003_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13193-021-01343-3","article-title":"Parathyroid carcinoma: a review","volume":"13","author":"Sawhney","year":"2022","journal-title":"Indian J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib57","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/j.prro.2017.05.009","article-title":"Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years","volume":"7","author":"Christakis","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib58","article-title":"The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: a national cancer database analysis","author":"Limberg","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2022.10.003_bib59","doi-asserted-by":"crossref","first-page":"102012","DOI":"10.1016\/j.ctrv.2020.102012","article-title":"Parathyroid cancer: An update","volume":"86","author":"Rodrigo","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"10.1016\/j.soc.2022.10.003_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid Cancer: A Review","volume":"11","author":"Machado","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.soc.2022.10.003_bib61","author":"Lerario"},{"key":"10.1016\/j.soc.2022.10.003_bib62","author":"Busaidy"},{"key":"10.1016\/j.soc.2022.10.003_bib63","article-title":"Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases","volume":"2017","author":"Rozhinskaya","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.soc.2022.10.003_bib64","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fendo.2019.00731","article-title":"The clinicopathological spectrum of parathyroid carcinoma","volume":"10","author":"Akirov","year":"2019","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib65","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s43018-022-00382-1","article-title":"The status of tumor mutational burden and immunotherapy","volume":"3","author":"Anagnostou","year":"2022","journal-title":"Nat Cancer"},{"issue":"11","key":"10.1016\/j.soc.2022.10.003_bib66","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying cancers based on T-cell Infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2022.10.003_bib68","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4183\/aeb.2016.383","article-title":"Clinical significance of Pd-L1 expression in parathyroid cancer","volume":"12","author":"Du","year":"2016","journal-title":"Acta Endocrinol (Buchar)"},{"key":"10.1016\/j.soc.2022.10.003_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2018.06.013","article-title":"Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages","author":"Silva-Figueroa","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2022.10.003_bib70","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1200\/EDBK_160766","article-title":"Biomarkers for immunotherapy: current developments and challenges","volume":"35","author":"Spencer","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib71","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"6349","key":"10.1016\/j.soc.2022.10.003_bib72","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.soc.2022.10.003_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235293","article-title":"Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab","volume":"13","author":"Park","year":"2020","journal-title":"BMJ case Rep"},{"issue":"6","key":"10.1016\/j.soc.2022.10.003_bib74","doi-asserted-by":"crossref","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.soc.2022.10.003_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.4203","article-title":"Complete genomic landscape of a recurring sporadic parathyroid carcinoma","volume":"230","author":"Kasaian","year":"2013","journal-title":"J\u00a0Pathol"},{"issue":"3","key":"10.1016\/j.soc.2022.10.003_bib76","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/js.2018-00043","article-title":"Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways","volume":"3","author":"Clarke","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"8","key":"10.1016\/j.soc.2022.10.003_bib77","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"8","key":"10.1016\/j.soc.2022.10.003_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154943","article-title":"Targeting mutations in cancer","volume":"132","author":"Waarts","year":"2022","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.soc.2022.10.003_bib79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2016.10.007","article-title":"Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma","volume":"71","author":"Hsieh","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.soc.2022.10.003_bib80","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.31948","article-title":"Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas","volume":"144","author":"Cui","year":"2019","journal-title":"Int J Cancer"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:05:38Z","timestamp":1760961938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320722000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1055320722000837"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2022.10.003","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Nomogram for Relapse\/Death and Contemplating Adjuvant Therapy for Parathyroid Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}